Evidence map›Paper›PMID 39065074›Full record

ArticleMicroorganisms2024

Yu-Wei Chang, Yen-Ling Sun, Evelyn Chu, Yi-Yun Hung, Wei-Chieh Liao, Su-Min Tsai, Tsung-Han Lu, Pin-Chao Huang, Chin-Hsiu Yu, Shao-Yu Lee and 2 more

Abstract read
In one paragraph

Article in Microorganisms, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Review
  2. Review
  3. Oral Intake ofBiomedicines · 2025
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Yu-Wei ChangDepartment of Medical Laboratory and Biotechnology, Chung Shan Medical University, Taichung 40201, Taiwan.ORCID 0000-0003-1510-2598
Yen-Ling SunDepartment of Medical Laboratory and Biotechnology, Chung Shan Medical University, Taichung 40201, Taiwan.
Evelyn ChuDepartment of Medical Laboratory and Biotechnology, Chung Shan Medical University, Taichung 40201, Taiwan.
Yi-Yun HungDepartment of Medical Laboratory and Biotechnology, Chung Shan Medical University, Taichung 40201, Taiwan.
Wei-Chieh LiaoDepartment of Medical Laboratory and Biotechnology, Chung Shan Medical University, Taichung 40201, Taiwan.
Su-Min TsaiDepartment of Medical Laboratory and Biotechnology, Chung Shan Medical University, Taichung 40201, Taiwan.
Tsung-Han LuInstitute of Medicine, Chung Shan Medical University, Taichung 40201, Taiwan.
Pin-Chao HuangPercheron Bioceutical Co., Ltd., Taichung 40201, Taiwan.
Chin-Hsiu YuPercheron Bioceutical Co., Ltd., Taichung 40201, Taiwan.ORCID 0009-0009-9879-7321
Shao-Yu LeePercheron Bioceutical Co., Ltd., Taichung 40201, Taiwan.
Han-Hsin ChangDepartment of Nutrition, Chung Shan Medical University, Taichung 40201, Taiwan.ORCID 0000-0003-4570-1268
David Pei-Cheng LinDepartment of Medical Laboratory and Biotechnology, Chung Shan Medical University, Taichung 40201, Taiwan.ORCID 0000-0002-8658-9703

Funding

Percheron Bioceutical Co. Ltd., Taichung, Taiwan CSMU 111-Academic-Industry-106)
6 · The paper itself

Abstract

Dry eye is a complicated ocular surface disease that causes discomfort, visual disturbance, and frequently observed ocular surface damage. Emerging hypotheses suggest probiotics may help relieve dry eye symptoms by modulating inflammation and oxidative stress. This study aimed to investigate the therapeutic effects of

Indexed as

dry eye symptomsmouse modelocular surface damageprobioticsStreptococcus thermophilustear film breakup timetear film stabilitytear volume

Identifiers

PMID39065074
PMCPMC11279365

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.